Eric G Friedman, MD | |
552 W Lincolnway, Valparaiso, IN 46385-5531 | |
(219) 464-3937 | |
(219) 462-1534 |
Full Name | Eric G Friedman |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 552 W Lincolnway, Valparaiso, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164620530 | NPI | - | NPPES |
100208400A | Medicaid | IN | |
000000102346 | Other | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 01028202 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Eric G Friedman, MD 552 W Lincolnway, Valparaiso, IN 46385-5531 Ph: (219) 464-3937 | Eric G Friedman, MD 552 W Lincolnway, Valparaiso, IN 46385-5531 Ph: (219) 464-3937 |
News Archive
Although extensive studies have been carried out on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and evidence exists that pregnant women are at elevated risk of severe COVID-19, the impact of maternal infection on the fetus is not clear. The majority of pregnant women infected with SARS-CoV-2 are asymptomatic or experience mild symptoms.
In just two years, the powerful opioid fentanyl went from nonexistent to detected in more than 1 in 7 stamp bags analyzed by the Allegheny County Office of the Medical Examiner, according to an analysis led by the University of Pittsburgh Graduate School of Public Health. Stamp bags are small wax packets that contain mixtures of illicit drugs, most commonly heroin, packaged for sale and sometimes stamped with a graphical logo by drug dealers to market their contents.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled "Methods for Treatment with Bucindolol Based on Genetic Targeting." The Notice of Allowance is the USPTO's official communication that the examination of the patent application has been successfully completed and that a patent will be issued.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
A recent review paper in the journal Current Opinion in Virology in September 2020 shows how a new generation of RNA vaccines called self-amplifying RNA vaccines are more potent than conventional mRNA vaccines and could hold the key to the global production of cost-effective potent COVID-19 vaccines.
› Verified 2 days ago
Judy L Davis, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 807 Glendale Blvd, Valparaiso, IN 46384 Phone: 219-531-1999 Fax: 219-465-7569 | |
John L Felton, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1620 Country Club Rd, Suite D, Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 | |
Anusha Vasamsetti, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd, Valparaiso, IN 46383 Phone: 219-462-0309 | |
Scott A Buck, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 502 Marquette St, Valparaiso, IN 46383 Phone: 219-464-8223 Fax: 219-531-2356 | |
Myron I Lewyckyj, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd., Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 | |
Daniel P Taglia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd., Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 |